MarketCapExport financials
Molecular Data (MKD)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Molecular Data Income Statement 2021-2011 | MKD
Annual Income Statement Molecular Data
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
- | 6.95 B | 13.6 B | - | - | - | - | - | - | - | - |
Shares |
- | 348 M | 311 M | 311 M | 311 M | - | - | - | - | - | - |
Historical Prices |
2.31 | 19.9 | 43.8 | - | - | - | - | - | - | - | - |
Net Income |
- | -328 M | -194 M | -255 M | -108 M | -114 M | - | - | - | - | - |
Revenue |
- | 7.6 B | 13.2 B | 9.05 B | 4.2 B | 3.21 B | - | - | - | - | - |
Cost of Revenue |
- | 7.61 B | 13.1 B | 8.97 B | 4.15 B | - | - | - | - | - | - |
Gross Profit |
- | -10.2 M | 101 M | 80.2 M | 50.2 M | 26.1 M | - | - | - | - | - |
Operating Income |
- | -332 M | -192 M | -236 M | -91.2 M | - | - | - | - | - | - |
Interest Expense |
- | 10.7 M | 4.37 M | 19 M | 16.8 M | - | - | - | - | - | - |
EBITDA |
- | -331 M | -191 M | -234 M | -89.7 M | -105 M | - | - | - | - | - |
Operating Expenses |
- | 321 M | 293 M | 316 M | 141 M | 132 M | - | - | - | - | - |
General and Administrative Expenses |
- | 210 M | 104 M | 174 M | 41.7 M | 41.8 M | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in CNY currency
Quarterly Income Statement Molecular Data
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | - | - | - | - | - | - | - | 348 M | - | - | - | 311 M | - | - | - | 311 M | - | - | - | 311 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
- | - | - | - | - | - | - | - | -328 M | - | - | - | -194 M | - | - | - | -255 M | - | - | - | -108 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | 7.6 B | - | - | - | 13.2 B | - | - | - | 9.05 B | - | - | - | 4.2 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | 7.61 B | - | - | - | 13.1 B | - | - | - | 8.97 B | - | - | - | 4.15 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | -10.2 M | - | - | - | 101 M | - | - | - | 80.2 M | - | - | - | 50.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | - | - | - | - | - | -332 M | - | - | - | -192 M | - | - | - | -236 M | - | - | - | -91.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | 10.7 M | - | - | - | 4.37 M | - | - | - | 19 M | - | - | - | 16.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | - | - | - | - | -331 M | - | - | - | -191 M | - | - | - | -234 M | - | - | - | -89.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | 321 M | - | - | - | 293 M | - | - | - | 316 M | - | - | - | 141 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | - | - | - | - | - | - | - | 210 M | - | - | - | 104 M | - | - | - | 174 M | - | - | - | 41.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in CNY currency
The income statement is one of the three key financial reports of a company Molecular Data (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Chemicals industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Казаньоргсинтез
KZOS
|
- | - | - |  Russia |
 |
Methanex Corporation
MEOH
|
$ 68.12 | 2.45 % | $ 4.94 B |  Canada |
 |
DuPont de Nemours
DD
|
$ 156.26 | 0.72 % | $ 65.2 B |  USA |
 |
Куйбышевазот
KAZT
|
- | - | - | Russia |
 |
Braskem S.A.
BAK
|
$ 1.12 | -0.45 % | $ 462 M |  Brasil |
 |
Роллман
RLMN
|
- | - | - | Russia |
 |
Westlake Chemical Partners LP
WLKP
|
$ 21.37 | 1.69 % | $ 753 M | USA |
 |
Huntsman Corporation
HUN
|
$ 9.5 | -0.42 % | $ 1.64 B | USA |
 |
Univar Solutions
UNVR
|
- | -0.01 % | $ 5.99 B | USA |
 |
Adicet Bio
ACET
|
$ 2.98 | -0.5 % | $ 20.5 M | USA |
 |
Tronox Holdings plc
TROX
|
$ 2.85 | 4.98 % | $ 452 M | USA |
 |
Air Products and Chemicals
APD
|
$ 312.0 | 0.3 % | $ 69.5 B | USA |
 |
Dow
DOW
|
$ 31.49 | 1.71 % | $ 22.4 B | USA |
 |
Celanese Corporation
CE
|
$ 48.7 | -0.1 % | $ 5.33 B | USA |
 |
FutureFuel Corp.
FF
|
$ 3.12 | -38.46 % | $ 137 M | USA |
 |
AdvanSix
ASIX
|
$ 15.38 | -1.6 % | $ 414 M | USA |
 |
Ashland Global Holdings
ASH
|
$ 76.91 | -1.02 % | $ 3.54 B | USA |
 |
LSB Industries
LXU
|
$ 11.12 | 3.49 % | $ 799 M | USA |
 |
Eastman Chemical Company
EMN
|
$ 65.46 | 0.11 % | $ 7.51 B | USA |
 |
Rayonier Advanced Materials
RYAM
|
$ 5.59 | -1.76 % | $ 373 M | USA |
 |
Sociedad Química y Minera de Chile S.A.
SQM
|
$ 54.42 | -4.02 % | $ 15.5 B |  Chile |
 |
Ciner Resources LP
CINR
|
- | 0.81 % | $ 344 M | USA |
 |
Valhi
VHI
|
$ 16.26 | 0.25 % | $ 463 M | USA |
 |
Minerals Technologies
MTX
|
$ 61.87 | -1.15 % | $ 1.94 B | USA |
 |
Нижнекамскнефтехим
NKNC
|
- | - | - | Russia |